Inventor · disambiguated record
Shunhai Wang
Also filed as: WANG SHUNHAI
58 granted patents·33 pending applications·191 citations·filing 2018–2025
98Inventor score
Top patents by PatentIndex Score
91 records- 0198US12012445B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jun 18, 2024·4 cites·30 claims
- 0298US11958894B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Apr 16, 2024·5 cites·30 claims
- 0398US11732025B2Anti-VEGF protein compositions and methods for producing the sameREGENERAN PHARMACEUTICALS INC·Filed 2022·Granted Aug 22, 2023·11 cites·30 claims
- 0498US11548932B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Jan 10, 2023·8 cites·30 claims
- 0598US11542317B1Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Jan 3, 2023·11 cites·30 claims
- 0698US11505593B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·13 cites·29 claims
- 0798US11485770B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 1, 2022·6 cites·14 claims
- 0898US11459373B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Oct 4, 2022·8 cites·16 claims
- 0998US11459374B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Oct 4, 2022·13 cites·26 claims
- 1098US11306135B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Apr 19, 2022·7 cites·16 claims
- 1198US11299532B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Apr 12, 2022·8 cites·22 claims
- 1298US11186625B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 30, 2021·10 cites·3 claims
- 1398US11174283B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Nov 16, 2021·13 cites·12 claims
- 1498US11053280B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Jul 6, 2021·19 cites·11 claims
- 1597US12054532B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 6, 2024·2 cites·30 claims
- 1697US12049489B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jul 30, 2024·2 cites·30 claims
- 1797US12012444B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2023·Granted Jun 18, 2024·2 cites·19 claims
- 1897US11753459B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Sep 12, 2023·5 cites·30 claims
- 1997US11535663B2Methods for producing aflibercept in chemically defined media having reduced aflibercept variantsREGENERON PHARMA·Filed 2021·Granted Dec 27, 2022·6 cites·10 claims
- 2097US11472861B2Methods for producing aflibercept in chemically defined media having reduced aflibercept variantsREGENERON PHARMA·Filed 2021·Granted Oct 18, 2022·5 cites·26 claims
- 2197US11407813B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 9, 2022·3 cites·20 claims
- 2297US11104715B2Methods for producing aflibercept in chemically defined media having reduced aflibercept variantsREGENERON PHARMA·Filed 2020·Granted Aug 31, 2021·5 cites·16 claims
- 2396US11899023B2Quantitation and identification of dimers in co-formulationsREGENERON PHARMA·Filed 2022·Granted Feb 13, 2024·2 cites·8 claims
- 2496US11536725B2Quantitation and identification of dimers in co-formulationsREGENERON PHARMA·Filed 2020·Granted Dec 27, 2022·4 cites·9 claims
- 2594US12338274B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jun 24, 2025·0 cites·30 claims
- 2694US12319728B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jun 3, 2025·0 cites·30 claims
- 2794US12202883B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Granted Jan 21, 2025·0 cites·12 claims
- 2894US12000811B2Method and system of identifying and quantifying antibody fragmentationREGENERON PHARMA·Filed 2022·Granted Jun 4, 2024·1 cites·21 claims
- 2994US11505594B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·1 cites·27 claims
- 3094US11180540B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 23, 2021·2 cites·28 claims
- 3194US2025197474A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3293US2024294606A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3392US11835528B2System and method of analysis of a protein using liquid chromatography-mass spectrometryREGENERON PHARMA·Filed 2021·Granted Dec 5, 2023·1 cites·25 claims
- 3492US11345929B2Methods for analysis of viral capsid protein compositionREGENERON PHARMA·Filed 2019·Granted May 31, 2022·3 cites·20 claims
- 3590US10908166B2Dual-column LC-MS system and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Feb 2, 2021·2 cites·19 claims
- 3689US11385239B2Method and system of identifying and quantifying a proteinREGENERON PHARMA·Filed 2019·Granted Jul 12, 2022·2 cites·20 claims
- 3788US12480139B2Methods for analysis of viral capsid protein compositionREGENERON PHARMA·Filed 2023·Granted Nov 25, 2025·0 cites·20 claims
- 3888US12320790B2Method and system of identifying and quantifying antibody fragmentationREGENERON PHARMA·Filed 2024·Granted Jun 3, 2025·0 cites·20 claims
- 3988US10718754B2System and method for characterizing protein dimerizationREGENERON PHARMA·Filed 2019·Granted Jul 21, 2020·2 cites·22 claims
- 4087US12054533B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Aug 6, 2024·0 cites·18 claims
- 4186US12399182B2Quantitation and identification of dimers in co-formulationsREGENERON PHARMA·Filed 2023·Granted Aug 26, 2025·0 cites·28 claims
- 4286US11525833B2Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysisREGENERON PHARMA·Filed 2020·Granted Dec 13, 2022·1 cites·25 claims
- 4386US2025289868A1Anti-vegf protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 4485US12174199B2System and method of analysis of a protein using liquid chromatography-mass spectrometryREGENERON PHARMA·Filed 2023·Granted Dec 24, 2024·0 cites·33 claims
- 4585US12169204B2Coupled native mass spectrometry for antibody analysisREGENERON PHARMA·Filed 2023·Granted Dec 17, 2024·0 cites·15 claims
- 4684US11579150B2Methods for characterizing disulfide bondsREGENERON PHARMA·Filed 2020·Granted Feb 14, 2023·1 cites·16 claims
- 4784US11525823B2System and method for characterizing protein dimerizationREGENERON PHARMA·Filed 2020·Granted Dec 13, 2022·1 cites·30 claims
- 4884US11249089B2System and method of analysis of a protein using liquid chromatography-mass spectrometryREGENERON PHARMA·Filed 2019·Granted Feb 15, 2022·1 cites·18 claims
- 4984US2023393141A1Dual-column lc-ms system and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 5083US12000839B2Methods for characterizing disulfide bondsREGENERON PHARMA·Filed 2023·Granted Jun 4, 2024·0 cites·18 claims
Showing the top 50 of 91 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shunhai Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →